155 related articles for article (PubMed ID: 20487051)
1. Rhythm control agents and adverse events in patients with atrial fibrillation.
Taylor CJ; Hodgkinson J; Hobbs FD
Int J Clin Pract; 2010 Jul; 64(8):1069-75. PubMed ID: 20487051
[TBL] [Abstract][Full Text] [Related]
2. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
4. One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis.
Kim MH; Smith PJ; Jhaveri M; Lin J; Klingman D
Clin Ther; 2011 Nov; 33(11):1668-1681.e1. PubMed ID: 22108302
[TBL] [Abstract][Full Text] [Related]
5. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
[TBL] [Abstract][Full Text] [Related]
6. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
[TBL] [Abstract][Full Text] [Related]
7. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.
Freemantle N; Lafuente-Lafuente C; Mitchell S; Eckert L; Reynolds M
Europace; 2011 Mar; 13(3):329-45. PubMed ID: 21227948
[TBL] [Abstract][Full Text] [Related]
8. Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics.
Wu C; Tcherny-Lessenot S; Dai W; Wang Y; Kechemir H; Gandhi S; Lin S; Juhaeri J
Clin Ther; 2018 Mar; 40(3):450-455.e1. PubMed ID: 29500139
[TBL] [Abstract][Full Text] [Related]
9. Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainide.
Zarembski DG; Nolan PE; Slack MK; Caruso AC
Arch Intern Med; 1995 Sep; 155(17):1885-91. PubMed ID: 7677555
[TBL] [Abstract][Full Text] [Related]
10. Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs.
Friberg L
Am Heart J; 2018 Nov; 205():118-127. PubMed ID: 30236980
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone versus sotalol for atrial fibrillation.
Singh BN; Singh SN; Reda DJ; Tang XC; Lopez B; Harris CL; Fletcher RD; Sharma SC; Atwood JE; Jacobson AK; Lewis HD; Raisch DW; Ezekowitz MD;
N Engl J Med; 2005 May; 352(18):1861-72. PubMed ID: 15872201
[TBL] [Abstract][Full Text] [Related]
12. Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm?
Kochiadakis GE; Marketou ME; Igoumenidis NE; Chrysostomakis SI; Mavrakis HE; Kaleboubas MD; Vardas PE
Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1883-7. PubMed ID: 11139949
[TBL] [Abstract][Full Text] [Related]
13. Dronedarone: a promising alternative for the management of atrial fibrillation.
Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
Joseph AP; Ward MR
Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
[TBL] [Abstract][Full Text] [Related]
15. Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation.
Kochiadakis GE; Igoumenidis NE; Marketou ME; Solomou MC; Kanoupakis EM; Vardas PE
Am J Cardiol; 1998 Apr; 81(8):995-8. PubMed ID: 9576159
[TBL] [Abstract][Full Text] [Related]
16. The evolving landscape of oral anti-arrhythmic prescriptions for atrial fibrillation in England: 1998-2014.
Hayward C; Patel HC; Patel K; Di Mario C; Lyon AR; Ahsan SY; Rowland E
Eur Heart J Cardiovasc Pharmacother; 2016 Apr; 2(2):90-4. PubMed ID: 27418969
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.
AFFIRM First Antiarrhythmic Drug Substudy Investigators
J Am Coll Cardiol; 2003 Jul; 42(1):20-9. PubMed ID: 12849654
[TBL] [Abstract][Full Text] [Related]
18. Management of patients with acute atrial fibrillation in the ED.
Conti A; Del Taglia B; Mariannini Y; Pepe G; Vanni S; Grifoni S; Abbate R; Michelucci A; Padeletti L; Gensini GF
Am J Emerg Med; 2010 Oct; 28(8):903-10. PubMed ID: 20825922
[TBL] [Abstract][Full Text] [Related]
19. Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey.
Kowey PR; Breithardt G; Camm J; Crijns H; Dorian P; Le Heuzey JY; Pedrazzini L; Prystowsky EN; Salette G; Schwartz PJ; Torp-Pedersen C; Weintraub W
Clin Cardiol; 2010 Mar; 33(3):172-8. PubMed ID: 20235224
[TBL] [Abstract][Full Text] [Related]
20. Is either sotalol or amiodarone more effective than digoxin for converting patients with new-onset atrial fibrillation (AF) to sinus rhythm within 48 hours?
Forney AJ; Schooff M
J Fam Pract; 2000 Nov; 49(11):982. PubMed ID: 11093561
[No Abstract] [Full Text] [Related]
[Next] [New Search]
